On 2014 Aug 12, Karim Asehnoune commented:
In the CRASH trial, mild to severe TBI patients (GCS<14) were included, and a short course of high-dose methlyprednisolone was used. In the CORTI-TC study, only severe TBI patients (GCS<8 and abnormalities on brain CT-scan) were included, and low dose of steroids (hydrocortisone)+fludrocortisone were used. When comparing these 2 studies, one could say: the population is different, the drugs used are different, the outcomes are different. One book is closed, the other one remains open.
This comment, imported by Hypothesis from PubMed Commons, is licensed under CC BY.